Multiple sclerosis and Urobilinogen urine increased

Summary:

Urobilinogen urine increased is found among people with Multiple sclerosis, especially for people who are female, 50-59 old.

The study analyzes which people have Urobilinogen urine increased with Multiple sclerosis. It is created by eHealthMe based on reports of 56 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,084 drugs and 1,366 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

What is Urobilinogen urine increased?

Urobilinogen urine increased is found to be associated with 34 drugs and 133 conditions by eHealthMe. Check the latest studies of Urobilinogen urine increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

56 people who have Multiple Sclerosis and Urobilinogen Urine Increased are studied.

Would you have Urobilinogen urine increased when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experienced Urobilinogen Urine Increased *:

  • female: 52 %
  • male: 48 %

Age of people who have Multiple Sclerosis and experienced Urobilinogen Urine Increased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 4.08 %
  • 30-39: 18.37 %
  • 40-49: 24.49 %
  • 50-59: 53.06 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 11 people, 19.64%
  2. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 10 people, 17.86%
  3. Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 10 people, 17.86%
  4. Encephalomyelitis (inflammation of the brain and spinal cord): 10 people, 17.86%
  5. Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 8 people, 14.29%
  6. Gait Disturbance: 8 people, 14.29%
  7. Neuralgia (pain in one or more nerves): 5 people, 8.93%
  8. Poor Quality Sleep: 4 people, 7.14%
  9. Infection: 4 people, 7.14%
  10. Depression: 4 people, 7.14%

Common drugs taken by these people *:

  1. Gilenya: 19 people, 33.93%
  2. Lioresal: 10 people, 17.86%
  3. Lyrica: 10 people, 17.86%
  4. Vitamin B12: 10 people, 17.86%
  5. Clexane: 10 people, 17.86%
  6. Zoloft: 7 people, 12.50%
  7. Ambien: 7 people, 12.50%
  8. Zanaflex: 6 people, 10.71%
  9. Colace: 5 people, 8.93%
  10. Vasotec: 4 people, 7.14%

Common symptoms for these people *:

  1. Lymphocyte Count Decreased: 39 people, 69.64%
  2. Lymphocyte Percentage Decreased: 29 people, 51.79%
  3. Neutrophil Percentage Increased: 25 people, 44.64%
  4. Alanine Aminotransferase Increased: 25 people, 44.64%
  5. Protein Urine Present: 23 people, 41.07%
  6. Monocyte Percentage Increased: 22 people, 39.29%
  7. Urinary Tract Infection: 21 people, 37.50%
  8. Red Blood Cells Urine Positive: 21 people, 37.50%
  9. White Blood Cells Urine Positive: 21 people, 37.50%
  10. Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 19 people, 33.93%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Urobilinogen urine increased?

- Check whether Urobilinogen urine increased is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Urobilinogen urine increased:

All the conditions that are associated with Urobilinogen urine increased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Urobilinogen urine increased and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: